Pubmatic, Inc. SEC Filings

Rajeev K. Goel, PubMatic, Inc. CEO, director and reported ~10% owner, filed a Form 4 reporting transactions dated 09/02/2025. The filing shows an acquisition entry of 44,000 shares of Class A common stock (non-derivative) and a sale of 44,000 shares at a weighted-average price of $8.4484, with the sale effected pursuant to a Rule 10b5-1 trading plan adopted March 2, 2025.

The report discloses related transfers of shares to The Goel Family Trust and notes that following the reported sales Mr. Goel holds 2,362,194 shares of Class A and Class B common stock (excluding unvested/vested-but-unexercised option amounts). The filing also records option activity: 44,000 options with a $1.11 exercise price that are fully vested and expire on 07/07/2026. The form is signed by an attorney-in-fact on 09/04/2025.

Amar K. Goel, who serves as Chairman and Chief Innovation Officer of PubMatic, Inc. and is identified as a director and 10% owner, sold 8,020 shares of Class A common stock on 09/02/2025. The shares were sold under a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2025. The reported weighted-average sale price was $8.4502, with individual sale prices ranging from $8.34 to $8.58. Following the reported sale, the reporting person beneficially owned 12,496 shares of Class A common stock. The Form 4 was submitted by an attorney-in-fact on the reporting person’s behalf.

PubMatic, Inc. (PUBM) Form 144 notifies a proposed sale of 44,000 common shares through Goldman Sachs & Co. LLC with an aggregate market value of $374,880, to be sold on 09/02/2025 on NASD. The filer reports those shares were acquired on 09/02/2025 upon option exercise and paid by option exercise. The filing also discloses multiple prior sales by the Goel Family Trust totaling repeated dispositions between 06/02/2025 and 08/18/2025, including several 44,000-share transactions and one large reported gross proceeds entry of $4,849,280. The filer affirms no undisclosed material adverse information and certifies compliance with Rule 144 representations.

PubMatic, Inc. (PUBM) Form 144 notifies the SEC of a proposed sale of 8,020 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $69,533.40. The shares were acquired as restricted stock units on 07/01/2025 and are listed for an approximate sale date of 09/02/2025. The filing also discloses that Amar Goel sold 4,417 shares on 07/02/2025 for $55,492.10. The filing shows 37,459,793 shares outstanding for the issuer. The filer affirms there is no undisclosed material adverse information and relies on Rule 144 procedures for restricted securities previously issued to an insider.

Steven Pantelick, Chief Financial Officer of PubMatic, Inc. (PUBM), reported a sale of Class A common stock under a pre-established Rule 10b5-1 trading plan. The filing discloses that on 08/27/2025 he sold 3,676 shares at a weighted-average price of $8.4363, with prices in the range $8.31 to $8.52. After the reported sale, the filing shows the reporting person beneficially owned 27,026 shares. The Form 4 was signed by an attorney-in-fact on 08/29/2025. All sales were effected pursuant to the 10b5-1 plan adopted May 9, 2024.

Form 144 notice for PubMatic, Inc. (PUBM): An individual affiliated with the company is proposing to sell 3,676 shares of common stock under Rule 144, with an approximate aggregate market value of $30,621.08, and an approximate sale date of 08/27/2025 on NASDAQ through Morgan Stanley Smith Barney LLC.

The shares reported to be sold were acquired as Restricted Stock Units on 07/01/2025 from the issuer. The filing also discloses three recent sales by the same person or related 10b5-1 plans: 15,690 shares on 07/03/2025 (gross proceeds $201,220.34), 15,598 shares on 07/02/2025 (gross proceeds $195,545.89), and 4,000 shares on 06/03/2025 (gross proceeds $48,262.80).

Rajeev K. Goel, PubMatic, Inc. director, CEO and >10% owner, reported insider transactions on 08/18/2025. He exercised 44,000 options with a $1.11 exercise price and acquired the underlying shares, and 44,000 Class A shares were sold pursuant to a Rule 10b5-1 trading plan at a weighted average sale price of $8.4183 per share (range $8.31–$8.515). The sold shares were transferred to and sold by The Goel Family Trust. After the transactions, Mr. Goel beneficially holds 2,362,194 shares of Class A and Class B common stock, excluding unvested or unexercised option awards. Several additional share blocks are held indirectly in trusts for family members, and the exercised options are fully vested and expire on 07/07/2026.

PubMatic, Inc. (PUBM) Form 4 summary: Lisa Gimbel, Chief Accounting Officer, reported the vesting and settlement of multiple restricted stock unit awards and a small related sale to cover tax withholding. On August 15, 2025, three RSU vesting events were reported that added 1,395; 773; and 802 shares to her beneficial ownership. After those settlements her reported beneficial holdings increased to 11,160; 7,726; and 11,218 shares across the respective RSU series. On August 18, 2025, she sold 1,062 shares in a block trade at a weighted average price of $8.4081 per share to satisfy tax withholding obligations.

The filing clarifies that each RSU converts to one share on vesting for no consideration and describes the vesting schedules for the different RSU grants. The sale price range for the block trade was $8.30 to $8.515 and the reporting person can provide detailed allocation information on request.

PubMatic, Inc. (PUBM) filing a Form 144 notifies the proposed sale of 44,000 common shares through Goldman Sachs & Co. LLC on 08/18/2025. The shares were acquired the same day upon exercise of options and the aggregate market value of the planned sale is listed as $372,240. The filing shows the selling account has completed multiple open-market sales of common stock during the prior three months, with individual proceeds ranging from $100,623 to $4,849,280, and multiple sale dates between 05/05/2025 and 08/01/2025. The filing includes a seller representation that no undisclosed material adverse information is known.